Design, synthesis, and biological activity of novel purine and bicyclic pyrimidine factor Xa inhibitors

被引:52
作者
Buckman, BO [1 ]
Mohan, R [1 ]
Koovakkat, S [1 ]
Liang, A [1 ]
Trinh, L [1 ]
Morrissey, MM [1 ]
机构
[1] Berlex Biosci, Pharmaceut Discovery, Richmond, CA 94804 USA
关键词
D O I
10.1016/S0960-894X(98)00386-2
中图分类号
R914 [药物化学];
学科分类号
100701 [药物化学];
摘要
The synthesis of amidinoaryloxy 9-benzyl-8-methyl-9H-purine, 7,8-dihydropteridine-6(5H)-one and 5,7-dihydropyrimido[4,5-b][1,4]oxazine-6-one inhibitors of Factor Xa is described. These compounds show nanomolar potency against FXa and maintain high selectivity over thrombin and trypsin. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2235 / 2240
页数:6
相关论文
共 16 条
[1]
X-ray structure of active site-inhibited clotting factor Xa - Implications for drug design and substrate recognition [J].
Brandstetter, H ;
Kuhne, A ;
Bode, W ;
Huber, R ;
vonderSaal, W ;
Wirthensohn, K ;
Engh, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (47) :29988-29992
[2]
BUCKMAN BO, 1998, 215 ACS NAT M DALL M
[3]
DAVEY DD, 1998, 215 ACS NAT M DALL M
[4]
GUILFORD WJ, 1998, 215 ACS NAT M DALL M
[5]
MANN KG, 1990, BLOOD, V76, P1
[7]
NG HP, 1998, 215 ACS NAT M DALL M
[8]
OKADA K, 1988, TETRAHEDRON LETT, V39, P4403
[9]
PHILLIPS GB, 1998, 215 ACS NAT M DALL M
[10]
PHILLIPS GO, IN PRESS